Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stege

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Naunyn-Schmiedebergs Archiv Fur Pharmakologie|January 1, 1970
[Relation between inhibition of acetylcholinesterase and binding of 3H-diisopropylphosphorofluoridate under the influence of alkane-bis-ammonium compounds]F K Ohnesorge, R Stege, A Ziegler
International Journal of Andrology|August 1, 1987
Orchidectomy or oestrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroidsR Stege, A Eriksson, P Henriksson, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1990
Serum hormone levels in men with end stage renal diseaseK Carlström, A Pousette, R Stege, et al.
The Prostate|September 19, 1997
Transurethral microwave thermotherapy in symptomatic benign prostatic hyperplasia: a possible association between androgen status and treatment result?A Hallin, R Stege, T Berlin, et al.
International Journal of Andrology|February 1, 1990
Relationship between serum testosterone and sex hormone-binding globulin in adult men with intact or absent gonadal functionK Carlström, A Eriksson, R Stege, et al.
Calcified Tissue International|August 1, 1995
Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogensS Eriksson, A Eriksson, R Stege, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|March 31, 1999
Tissue PSA is the best predicting variable for the outcome of endocrine treatment of prostatic carcinomaA Pousette, M Grande, K Carlström, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1991
Effects of orchidectomy and different modes of high dose estrogen treatment on circulating "free" and total 1,25-dihydroxyvitamin D in patients with prostatic cancerY Hagenfeldt, K Carlström, T Berlin, et al.
The Prostate|May 15, 1997
Use of a hormone-sensitive (LNCaP) and a hormone-resistant (LNCaP-r) cell line in prostate cancer researchA Pousette, K Carlström, P Henriksson, et al.
British Journal of Urology|March 1, 1990
Effect of parenteral oestrogen on the coagulation system in patients with prostatic carcinomaP Henriksson, M Blombäck, A Eriksson, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Naunyn-Schmiedebergs Archiv Fur Pharmakologie|January 1, 1970
[Relation between inhibition of acetylcholinesterase and binding of 3H-diisopropylphosphorofluoridate under the influence of alkane-bis-ammonium compounds]F K Ohnesorge, R Stege, A Ziegler
International Journal of Andrology|August 1, 1987
Orchidectomy or oestrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroidsR Stege, A Eriksson, P Henriksson, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1990
Serum hormone levels in men with end stage renal diseaseK Carlström, A Pousette, R Stege, et al.
The Prostate|September 19, 1997
Transurethral microwave thermotherapy in symptomatic benign prostatic hyperplasia: a possible association between androgen status and treatment result?A Hallin, R Stege, T Berlin, et al.
International Journal of Andrology|February 1, 1990
Relationship between serum testosterone and sex hormone-binding globulin in adult men with intact or absent gonadal functionK Carlström, A Eriksson, R Stege, et al.
Calcified Tissue International|August 1, 1995
Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogensS Eriksson, A Eriksson, R Stege, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|March 31, 1999
Tissue PSA is the best predicting variable for the outcome of endocrine treatment of prostatic carcinomaA Pousette, M Grande, K Carlström, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1991
Effects of orchidectomy and different modes of high dose estrogen treatment on circulating "free" and total 1,25-dihydroxyvitamin D in patients with prostatic cancerY Hagenfeldt, K Carlström, T Berlin, et al.
The Prostate|May 15, 1997
Use of a hormone-sensitive (LNCaP) and a hormone-resistant (LNCaP-r) cell line in prostate cancer researchA Pousette, K Carlström, P Henriksson, et al.
British Journal of Urology|March 1, 1990
Effect of parenteral oestrogen on the coagulation system in patients with prostatic carcinomaP Henriksson, M Blombäck, A Eriksson, et al.
Pageof 5